Industry Symposia

Morning Symposia: Breakfast will be served to session participants from 07:00-07:30, half an hour prior to the start of the session.
Lunch Symposia: Lunch boxes will be served to session participants.

Admission to all industry symposia is included as part of the congress registration.

Friday, October 14, 2022

07:30-08:30
Hall A
(Great Hall 1)
Morning Industry Symposium
The role of Enhertu (trastuzumab-deruxtecan) in changing the treatment paradigm for HER2-positive Metastatic Breast Cancer
Supported by AstraZeneca
ASTRAZENECA
07:30-08:30
Hall B
(Great Hall 2)
Morning Industry Symposium:
DCISionRT: Personalising treatment for women with DCIS
Supported by GenesisCare/PreludeDX

Genesis
07:30-08:30
Hall C
(Room M1)
Morning Industry Symposium:
Risk adjusted screening
Supported by Hologic
08:30-09:30
Hall C
(Room M1)
Industry Symposium:
Evolution of treatment sequencing in patients with mTNBC
Supported by Gilead
11:30-12:30
Hall B
(Great Hall 2)

Industry Symposium:
I
mproving outcomes in high-risk HER2-positive patients post-KATHERINE
Supported by an educational/research sponsorship by Roche
11:30-12:30
Hall C
(Room M1)

Industry Symposium:
Touch and go: Removing the guesswork in detecting residual cancer
Supported by OncoRes

Saturday, October 15, 2022

07:30-08:30
Hall A
(Great Hall 1)

Morning Industry Symposium:
Future-proofing breast surgical guidance with Sentimag®
A total magnetic conversion
Supported by Endomag/GRC Surgical

07:30-08:30
Hall B
(Great Hall 2)

Morning Industry Symposium:
Time to start CDK4&6 inhibition in EBC: Verzenio in HR+ HER2- node positive EBC at high risk of recurrence
Supported by Lilly
07:30-08:30
Hall C
(Room M1)
Morning Industry Symposium:
The role of the nurse in assessing, triaging and managing metastatic TNBC
Supported by Gilead
10:00-11:00
Hall B
(Great Hall 2)

Industry Symposium: 
A CDK4/6i is a ‘once in a lifetime treatment’ for patients with
HR +ve HER2 -ve breast cancer
Supported by Novartis
Novartis
13:10-13:55
Hall B
(Great Hall 2)
Industry Lunch Symposium:
Innovative approaches to help improve patient outcomes:
Case-based discussion
Supported by 3M
Skip to content